Insider · CIK 0001654435

Danziger Asaf

Reports to the SEC for 1 company · WAYNE, PA

sec.gov

Transactions

Companies

Filings

CIK

0001654435

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-30	NVCRNovoCure LtdA Award	Director	AAward	+268 sh	$11.15	+$2,988.2	416,742
2025-12-31	NVCRNovoCure LtdA Award	Director	AAward	+1 sh	$10.99	+$10.99	416,474
2025-06-30	NVCRNovoCure LtdA Award	Director	AAward	+833 sh	$15.13	+$12.6K	416,473
2025-01-01	NVCRNovoCure LtdA Award	Director	AAward	+400K sh	—	—	415,640
2024-12-31	NVCRNovoCure LtdA Award	Director	AAward	+412 sh	$14.75	+$6,076.176	15,640
2024-06-28	NVCRNovoCure LtdA Award	Director	AAward	+1,239 sh	$12.24	+$15.2K	15,228
2023-06-30	NVCRNovoCure LtdA Award	Director	AAward	+367 sh	$35.28	+$12.9K	13,989
2023-01-06	NVCRNovoCure LtdA Award	Director	AAward	+39 sh	$62.30	+$2,429.895	13,622
2023-01-05	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+25K sh	$11.46	+$287K	38,583
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−8,369 sh	$111.23	−$931K	30,214
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−2,000 sh	$112.86	−$226K	28,214
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−4,568 sh	$114.35	−$522K	23,646
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−3,702 sh	$115.21	−$427K	19,944
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−1,395 sh	$116.06	−$162K	18,549
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−999 sh	$117.01	−$117K	17,550
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−2,123 sh	$118.47	−$252K	15,427
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−1,344 sh	$119.35	−$160K	14,083
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−500 sh	$119.99	−$60K	13,583
2023-01-05	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+188K sh	$7.15	+$1.34M	201,083
2023-01-05	NVCRNovoCure LtdS Sale	Director	SSale	−188K sh	$108.00	−$20.3M	13,583
2023-01-05	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−25K sh	—	—	0
2023-01-05	NVCRNovoCure Ltd · Options to Buy Ordinary SharesM Exercise/Conversion	Director	MExercise/Conversion	−188K sh	—	—	0
2022-07-05	NVCRNovoCure LtdA Award	Director	AAward	+276 sh	$59.08	+$16.3K	13,583
2022-03-03	NVCRNovoCure Ltd · Options to Buy Ordinary SharesA Award	Director	AAward	+13.5K sh	$80.59	+$1.09M	13,470
2022-01-06	NVCRNovoCure LtdA Award	Director	AAward	+31 sh	$63.82	+$1,978.358	13,307
2021-11-26	NVCRNovoCure LtdP Purchase	Director	PPurchase	+3,870 sh	$102.36	+$396K	12,172
2021-11-26	NVCRNovoCure LtdP Purchase	Director	PPurchase	+1,000 sh	$103.37	+$103K	13,172
2021-11-26	NVCRNovoCure LtdP Purchase	Director	PPurchase	+104 sh	$96.50	+$10K	13,276
2021-07-06	NVCRNovoCure LtdA Award	Director	AAward	+118 sh	$137.12	+$16.2K	8,302
2021-04-13	NVCRNovoCure LtdS Sale	Director	SSale	−98K sh	$196.34	−$19.2M	8,184
2021-02-27	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+9,259 sh	$149.10	+$1.38M	206,944
2021-02-27	NVCRNovoCure Ltd · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−9,259 sh	—	—	0
2021-01-06	NVCRNovoCure LtdA Award	Director	AAward	+53 sh	$50.67	+$2,685.457	197,685
2020-12-18	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+104K sh	$22.00	+$2.29M	301,587
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−21.6K sh	$155.24	−$3.36M	279,975
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−24.3K sh	$156.09	−$3.79M	255,689
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−24.7K sh	$157.04	−$3.87M	231,033
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−9,183 sh	$158.09	−$1.45M	221,850
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−4,500 sh	$159.32	−$717K	217,350
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−12.1K sh	$160.25	−$1.94M	205,258
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−3,500 sh	$160.99	−$563K	201,758
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−1,426 sh	$162.17	−$231K	200,332
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−1,300 sh	$162.97	−$212K	199,032
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−500 sh	$164.11	−$82.1K	198,532
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−700 sh	$165.38	−$116K	197,832
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−200 sh	$166.17	−$33.2K	197,632
2020-12-18	NVCRNovoCure LtdM Exercise/Conversion	Director	MExercise/Conversion	+104K sh	$22.00	+$2.29M	301,587
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−21.2K sh	$155.23	−$3.29M	280,380
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−25K sh	$156.08	−$3.9M	255,407
2020-12-18	NVCRNovoCure LtdS Sale	Director	SSale	−23.6K sh	$157.01	−$3.71M	231,806

Recent filings

Accepted (ET)
Jul 14
Danziger Asaf0001654435-26-000003
SEC(opens sec.gov)
Jan 85
Danziger Asaf0001654435-26-000001
SEC(opens sec.gov)
Jul 14
Danziger Asaf0001562180-25-005187
SEC(opens sec.gov)
Jan 34
Danziger Asaf0001562180-25-000065
SEC(opens sec.gov)
Aug 64
Danziger Asaf0001562180-24-006041
SEC(opens sec.gov)
Jul 64
Danziger Asaf0001562180-23-005755
SEC(opens sec.gov)
Jan 94
Danziger Asaf0001645113-23-000007
SEC(opens sec.gov)

Companies

NovoCure LtdDirectorNVCR

Address

C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115

WAYNE, PA, 19087